These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26867565)

  • 1. TAM receptor tyrosine kinase function and the immunopathology of liver disease.
    Mukherjee SK; Wilhelm A; Antoniades CG
    Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G899-905. PubMed ID: 26867565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.
    Gao L; He C; Yang A; Zhou H; Lu Q; Birge RB; Wu Y
    Cell Commun Signal; 2023 Aug; 21(1):195. PubMed ID: 37537628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer.
    Zagórska A; Través PG; Jiménez-García L; Strickland JD; Oh J; Tapia FJ; Mayoral R; Burrola P; Copple BL; Lemke G
    Life Sci Alliance; 2020 Aug; 3(8):. PubMed ID: 32571802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
    Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
    Elife; 2014 Sep; 3():. PubMed ID: 25265470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase.
    Kimani SG; Kumar S; Davra V; Chang YJ; Kasikara C; Geng K; Tsou WI; Wang S; Hoque M; Boháč A; Lewis-Antes A; De Lorenzo MS; Kotenko SV; Birge RB
    Cell Commun Signal; 2016 Sep; 14(1):19. PubMed ID: 27595981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of lung homeostasis and silicosis by the TAM receptors MerTk and Axl.
    Guimarães-Pinto K; Leandro M; Corrêa A; Maia EP; Rodrigues L; da Costa ALA; Rafael Machado Ferreira J; Claudio-Etienne E; Siebenlist U; He J; Rigoni TDS; Ferreira TPT; Jannini-Sa YAP; Matos-Guedes HL; Costa-da-Silva AC; Lopes MF; Silva PMR; Kelsall BL; Filardy AA
    Front Immunol; 2024; 15():1380628. PubMed ID: 38774866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
    Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
    J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer.
    Rothlin CV; Leighton JA; Ghosh S
    Inflamm Bowel Dis; 2014 Aug; 20(8):1472-80. PubMed ID: 24846720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic Coevolution of MER Tyrosine Kinase Expression and Function.
    Evans AL; Blackburn JWD; Taruc K; Kipp A; Dirk BS; Hunt NR; Barr SD; Dikeakos JD; Heit B
    Mol Biol Evol; 2017 Jul; 34(7):1613-1628. PubMed ID: 28369510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity.
    Davra V; Kumar S; Geng K; Calianese D; Mehta D; Gadiyar V; Kasikara C; Lahey KC; Chang YJ; Wichroski M; Gao C; De Lorenzo MS; Kotenko SV; Bergsbaken T; Mishra PK; Gause WC; Quigley M; Spires TE; Birge RB
    Cancer Res; 2021 Feb; 81(3):698-712. PubMed ID: 33239426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.
    Akalu YT; Rothlin CV; Ghosh S
    Immunol Rev; 2017 Mar; 276(1):165-177. PubMed ID: 28258690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
    Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
    Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
    Brown JE; Krodel M; Pazos M; Lai C; Prieto AL
    PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis.
    van den Brand BT; Abdollahi-Roodsaz S; Vermeij EA; Bennink MB; Arntz OJ; Rothlin CV; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2013 Mar; 65(3):671-80. PubMed ID: 23203851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
    Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
    Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis.
    Pagani S; Bellan M; Mauro D; Castello LM; Avanzi GC; Lewis MJ; Sainaghi PP; Pitzalis C; Nerviani A
    Dis Markers; 2020; 2020():1614627. PubMed ID: 32051695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakdown of immune homeostasis in the testis of mice lacking Tyro3, Axl and Mer receptor tyrosine kinases.
    Zhang Y; Li N; Chen Q; Yan K; Liu Z; Zhang X; Liu P; Chen Y; Han D
    Immunol Cell Biol; 2013 Jul; 91(6):416-26. PubMed ID: 23689306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
    Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
    Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells.
    Park HJ; Baen JY; Lee YJ; Choi YH; Kang JL
    Mol Biol Cell; 2012 Aug; 23(16):3254-65. PubMed ID: 22740630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.